
AMGEN WINS PATENT APPEAL ON OTEZLA® (APREMILAST)
AMGEN WINS PATENT APPEAL ON OTEZLA® (APREMILAST) Amgen (NASDAQ:AMGN) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the District of New Jersey in a patent infringement lawsuit against Sandoz Inc. (“Sandoz”) and Zydus Pharmaceuticals…